Company / Return on Assets (ROA)
MADRIGAL PHARMACEUTICALS, INC. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-22.9%
FY2025
5-year range
-88.5% / -22.9%
FY2021-FY2025
Trend
+48.8%
vs FY2024
Sector context
#107 of 213
Health Care
What the data says
At -22.9%, MADRIGAL PHARMACEUTICALS, INC.'s return on assets (roa) ranks #107 of 213 in the Health Care sector. Return on Assets (ROA) has increased for 4 consecutive years, from -88.5% in FY2021 to -22.9% in FY2025.
Based on SEC 10-K filings.
-22.9% in FY2025 with a 5-year CAGR of +47.6%.
Improved from -58.3% to -22.9% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- +58.6pp
- 5-Year Change
- +47.6pp
- 10-Year Change
- -
Sector benchmark
#107 of 213 in Health CareTop 50% of 213This company -22.9% Sector average -24.1%
▼
+5.2% above sector average
Key checks
Key Insights
- MADRIGAL PHARMACEUTICALS, INC.'s return on assets (roa) has grown for 4 consecutive years.
- In FY2025, return on assets (roa) increased 48.8% year-over-year.
- Currently 1.2pp above the Health Care sector average.
- Peak return on assets (roa) was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.47 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -22.9% | +48.8% |
| FY2024 | -44.7% | +23.4% |
| FY2023 | -58.3% | +28.4% |
| FY2022 | -81.5% | +7.9% |
| FY2021 | -88.5% | -25.6% |
| FY2020 | -70.5% | -271.1% |
| FY2019 | -19.0% | -180.9% |
| FY2018 | -6.8% | +58.3% |
| FY2017 | -16.2% | +74.7% |
| FY2016 | -64.0% | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026